Mark W. Lingen to Combined Modality Therapy
This is a "connection" page, showing publications Mark W. Lingen has written about Combined Modality Therapy.
Connection Strength
0.054
-
New therapeutic strategies for the treatment and prevention of head and neck cancer. Expert Opin Investig Drugs. 2000 Dec; 9(12):2855-72.
Score: 0.036
-
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2010 Jul 10; 28(20):3336-43.
Score: 0.018